BURNABY, British Columbia, Sept. 15, 2026 — Volta Peptides, a leading Canadian based supplier of research-grade peptides, today announced the rollout of a QR-coded batch-verification system designed to connect each newly labelled vial directly to the independent laboratory record for its production lot. The focus arrives against a documented quality problem in how these compounds are currently being supplied by competitors.
For example, Retatrutide 20mg, batch VPRT20100. The batch was tested by SideChain Analytics under report COA-2026-SC-02082, which reported 99.7% chromatographic purity and 29.26 mg of net peptide using HPLC-MS/MS on September 10, 2026.
Instead of directing purchasers to a general product page or a certificate associated only with the compound name, the QR code printed on the vial’s side panel opens SideChain Analytics’ verification page for the exact lot identified on the label. Each listings contains a CAS number, molecular formula and storage specifications.
The batch number printed beneath the QR code is also the lot number shown on the corresponding Certificate of Analysis. For the launch batch, VPRT20100 appears on the vial, the Volta Peptides product page and the independent laboratory report, creating a direct connection between the physical material and its analytical record.
“A Certificate of Analysis is only useful when a researcher can confirm that it applies to the material in front of them,” John from Volta Peptides said in announcing the launch. “Since our start, our mission has been to provide the highest quality and purity research peptides in Canada to Canadian and global researchers and institutions with same-day shipping and customer support that is unmatched.”
Verification Begins With the Vial
The side panel of every vial carries the information required to verify the individual batch:
- A unique batch number printed directly on the vial
- A QR code
- The product’s storage range
- The third-party testing designation
- The analytical methods used
- The product’s research-use-only classification
Scanning the code opens the laboratory’s verification record for that lot. Researchers without access to a camera can instead enter the batch number in Volta Peptides’ certificate archive and compare it with the lot number shown on the published report.
This approach is intended to eliminate the ambiguity created when one certificate is displayed for a compound without a clear connection to the production lot being supplied.
Specification, Purity and Quantity Are Reported Separately
Volta Peptides distinguishes between a catalogue specification and an independently measured batch result.
The company’s greater-than-99% purity specification and never underfilled policy is the minimum release standard a batch is required to meet by HPLC. Many come in higher than that, the recent certificate of anlysis show 99.9% purity for BPC-157 10mg, 99.7% for Retatrutide 20mg and 99.6% for Tirzepatide 30mg, all of which were 15-20% above the required minimum fill.
Purity and net peptide content answer different analytical questions. Chromatographic purity reports how much of the detected peptide material corresponds to the principal compound, while net peptide content measures the quantity of peptide present in the tested vial.
Publishing both figures gives researchers more information than a standalone purity percentage and allows the labelled quantity to be assessed independently from chromatographic composition.
“A purity claim on a homepage cannot identify the lot in a researcher’s hands,” Volta Peptides said. “A matching batch number, named laboratory, reported method, testing date and laboratory-controlled verification link create a record that can actually be checked.”
Volta Peptides products are supplied exclusively as research reference materials for qualified laboratory and in-vitro research.
About Volta Peptides
Volta Peptides Ltd is a Canadian supplier of research-grade peptides, proteins, amino-acid derivatives and reference materials. It’s offers
The company works with selected manufacturing partners and independently tests production batches using analytical methods including high-performance liquid chromatography and mass spectrometry. Its documentation system connects published Certificates of Analysis with the batch numbers shown on product pages and vial labels.
Orders are fulfilled from British Columbia, Canada. All products are supplied strictly for laboratory and in-vitro research use.
For additional information, visit voltapeptides.com.
Media Contact
Company Name: Volta Peptides Ltd
Contact Person: Johnathan Maurino
Email: Send Email
Country: Canada
Website: voltapeptides.com